DE69103630T2 - Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen. - Google Patents

Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen.

Info

Publication number
DE69103630T2
DE69103630T2 DE69103630T DE69103630T DE69103630T2 DE 69103630 T2 DE69103630 T2 DE 69103630T2 DE 69103630 T DE69103630 T DE 69103630T DE 69103630 T DE69103630 T DE 69103630T DE 69103630 T2 DE69103630 T2 DE 69103630T2
Authority
DE
Germany
Prior art keywords
pct
oxazole derivatives
production
pharmaceutical preparations
preparations containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69103630T
Other languages
English (en)
Other versions
DE69103630D1 (de
Inventor
Michel Barreau
Michel Kryvenko
Marc Lavergne
Auguste Techer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Roger Bellon SA
Original Assignee
Laboratoire Roger Bellon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Roger Bellon SA filed Critical Laboratoire Roger Bellon SA
Application granted granted Critical
Publication of DE69103630D1 publication Critical patent/DE69103630D1/de
Publication of DE69103630T2 publication Critical patent/DE69103630T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69103630T 1990-06-14 1991-06-13 Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen. Expired - Fee Related DE69103630T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9007388A FR2663331B1 (fr) 1990-06-14 1990-06-14 Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent.
PCT/FR1991/000473 WO1991019714A1 (fr) 1990-06-14 1991-06-13 Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE69103630D1 DE69103630D1 (de) 1994-09-29
DE69103630T2 true DE69103630T2 (de) 1995-01-12

Family

ID=9397581

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69103630T Expired - Fee Related DE69103630T2 (de) 1990-06-14 1991-06-13 Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen.

Country Status (21)

Country Link
US (1) US5403852A (de)
EP (1) EP0533827B1 (de)
JP (1) JPH05507710A (de)
KR (1) KR930700493A (de)
AT (1) ATE110381T1 (de)
AU (1) AU644454B2 (de)
CA (1) CA2080340A1 (de)
CS (1) CS180191A3 (de)
DE (1) DE69103630T2 (de)
DK (1) DK0533827T3 (de)
ES (1) ES2063513T3 (de)
FI (1) FI925191A (de)
FR (1) FR2663331B1 (de)
HU (1) HUT62888A (de)
IE (1) IE912019A1 (de)
IL (1) IL98488A0 (de)
NO (1) NO924634L (de)
NZ (1) NZ238524A (de)
PT (1) PT97974A (de)
WO (1) WO1991019714A1 (de)
ZA (1) ZA914516B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US6090834A (en) * 1993-05-21 2000-07-18 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
EP0825989A1 (de) * 1995-05-19 1998-03-04 G.D. Searle & Co. Substituierte oxazole zur behandlung von entzündung
US5942530A (en) * 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
US5952360A (en) * 1997-08-28 1999-09-14 Eli Lilly And Company Method for treating neuropathic pain
US7358254B2 (en) 2001-07-13 2008-04-15 Bristol-Myers Squibb Company Method for treating atherosclerosis employing an aP2 inhibitor and combination
BR9913833A (pt) 1998-09-17 2001-05-29 Bristol Myers Squibb Co Método para tratar diabetes, empregando em inibidor de ap2 e combinação
US7390824B1 (en) 1999-09-07 2008-06-24 Bristol-Myers Squibb Company Method for treating diabetes employing an aP2 inhibitor and combination
FR2800373B1 (fr) * 1999-10-27 2001-12-07 Oreal Procede de preparation d'oxazoles trisubstitues
TW200505446A (en) * 2003-01-17 2005-02-16 Fuj Isawa Pharmaceutical Co Ltd Inhibitor of cox
JP5912946B2 (ja) * 2012-01-11 2016-04-27 株式会社Adeka 感光性樹脂組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
US3546342A (en) * 1966-11-18 1970-12-08 Wyeth John & Brother Ltd Method of relieving inflammation by administration of 2,4 - diarylthiazole- 5 - alkanoic acids and derivatives thereof
FI53314C (fi) * 1967-06-14 1978-04-10 Wyeth John & Brother Ltd Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid)
US3586679A (en) * 1968-11-21 1971-06-22 Ciba Geigy Corp Process for the production of 2,4-dichloro-6-amino-s-triazines
GB1381860A (en) * 1971-06-03 1975-01-29 Wyeth John & Brother Ltd Tetrazole derivatives
DE2129012A1 (de) * 1971-06-11 1973-01-04 Merck Patent Gmbh Azol-derivate
GB1373352A (en) * 1972-04-27 1974-11-13 Wyeth John & Brother Ltd Oxazole derivatives
US5262540A (en) * 1989-12-20 1993-11-16 Bristol-Myers Squibb Company [2(4,5-diaryl-2 oxazoyl substituted phenoxy alkanoic acid and esters

Also Published As

Publication number Publication date
DK0533827T3 (da) 1994-09-26
ATE110381T1 (de) 1994-09-15
PT97974A (pt) 1992-03-31
AU8058391A (en) 1992-01-07
JPH05507710A (ja) 1993-11-04
FI925191A0 (fi) 1992-11-16
FR2663331A1 (fr) 1991-12-20
CS180191A3 (en) 1992-02-19
CA2080340A1 (fr) 1991-12-15
EP0533827B1 (de) 1994-08-24
NZ238524A (en) 1992-07-28
FI925191A (fi) 1992-11-16
HU9203942D0 (en) 1993-03-29
IE912019A1 (en) 1991-12-18
NO924634D0 (no) 1992-12-01
ZA914516B (en) 1992-03-25
ES2063513T3 (es) 1995-01-01
US5403852A (en) 1995-04-04
WO1991019714A1 (fr) 1991-12-26
KR930700493A (ko) 1993-03-15
DE69103630D1 (de) 1994-09-29
EP0533827A1 (de) 1993-03-31
AU644454B2 (en) 1993-12-09
NO924634L (no) 1992-12-01
FR2663331B1 (fr) 1994-05-06
HUT62888A (en) 1993-06-28
IL98488A0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
SE9100342D0 (sv) Novel steroid esters
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ATE33838T1 (de) Thiazolidinderivate, ihre herstellung und diese enthaltende zusammensetzungen.
RU95108387A (ru) Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
DE69103630D1 (de) Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen.
HUP0100184A2 (hu) Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények
PT81794B (pt) Processo de preparacao de novos derivados da pristinamicina iib e das suas composicoes farmaceuticas
ES478871A1 (es) Un procedimiento de preparacion de 2,6-dialcoxibenzamidas.
DE69018730D1 (de) Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE69320367D1 (de) Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
DK661088D0 (da) N-(23-vinblastinoyl)derivater af 1-aminomethylphosphonsyre, fremgangsmaade til deres fremstilling og farmaceutiske midelr indeholdende dem
ATE68494T1 (de) Benzofuranderivate und diese enthaltende therapeutische mittel.
ATE18211T1 (de) Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen.
FI870460A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-substituerade oktahydroindolizinderivat och vid foerfarandet anvaendbara mellanprodukter.
ES8206537A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina
ES8707951A1 (es) Derivados de tetrazol
ES2063157T3 (es) Nuevos derivados del indol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES8203910A1 (es) Procedimiento para la preparacion de 1,2-benzotiacinopirazo-les
ATE56440T1 (de) 6-oxo-pyridazinyl-verbindungen.
ES2068685T3 (es) Procedimiento de preparacion de nuevos derivados de 1,5-diin-cicloalquenos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee